(Q38147548)

29 August 2017

title

Improvement of surgical results for pancreatic cancer (English)

1 reference

29 August 2017

1 reference

4

Jürgen Debus

1 reference

29 August 2017

5

Markus W Büchler

1 reference

29 August 2017

Werner Hartwig

1

1 reference

29 August 2017

Jens Werner

series ordinal

2

1 reference

29 August 2017

Dirk Jäger

series ordinal

3

1 reference

29 August 2017

publication date

1 October 2013

1 reference

Lancet Oncology Commission

29 August 2017

published in

1 reference

29 August 2017

volume

14

1 reference

29 August 2017

issue

11

1 reference

29 August 2017

page(s)

e476-85

1 reference

Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970172-4

7 January 2021

Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970172-4

7 January 2021

Pancreatic cancer surgery in the new millennium: better prediction of outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970172-4

7 January 2021

Conditional survival in patients with pancreatic ductal adenocarcinoma resected with curative intent.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970172-4

7 January 2021

Pancreatic ductal adenocarcinoma: is there a survival difference for R1 resections versus locally advanced unresectable tumors? What is a "true" R0 resection?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970172-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970172-4

1 reference

7 January 2021

Pancreatic Adenocarcinoma, version 2.2012: featured updates to the NCCN Guidelines.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970172-4

7 January 2021

A randomized multicenter trial comparing resection and radiochemotherapy for resectable locally invasive pancreatic cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970172-4

7 January 2021

Pretreatment assessment of resectable and borderline resectable pancreatic cancer: expert consensus statement

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970172-4

7 January 2021

Preoperative tissue diagnosis for tumours of the pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970172-4

7 January 2021

Frequent detection of pancreatic lesions in asymptomatic high-risk individuals.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970172-4

7 January 2021

Invasive intraductal papillary mucinous neoplasm versus sporadic pancreatic adenocarcinoma: a stage-matched comparison of outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970172-4

7 January 2021

International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970172-4

7 January 2021

Branch-duct intraductal papillary mucinous neoplasms: observations in 145 patients who underwent resection

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970172-4

7 January 2021

Natural history of branch duct intraductal papillary mucinous neoplasms of the pancreas: a multicenter study in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970172-4

7 January 2021

Small (Sendai negative) branch-duct IPMNs: not harmless.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970172-4

7 January 2021

Incidental pancreatic cysts: do we really know what we are watching?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970172-4

7 January 2021

Pancreatic resections for cystic neoplasms: From the surgeon's presumption to the pathologist's reality

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970172-4

7 January 2021

Development of ductal carcinoma of the pancreas during follow-up of branch duct intraductal papillary mucinous neoplasm of the pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970172-4

7 January 2021

National failure to operate on early stage pancreatic cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970172-4

7 January 2021

A review of factors predicting perioperative death and early outcome in hepatopancreaticobiliary cancer surgery

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970172-4

7 January 2021

Postoperative pancreatic fistula: an international study group (ISGPF) definition.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970172-4

7 January 2021

Systematic review and meta-analysis of outcomes after intraoperative pancreatic duct stent placement during pancreaticoduodenectomy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970172-4

7 January 2021

Randomized clinical trial of external stent drainage of the pancreatic duct to reduce postoperative pancreatic fistula after pancreaticojejunostomy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970172-4

7 January 2021

Pancreaticojejunostomy versus pancreaticogastrostomy reconstruction after pancreaticoduodenectomy for pancreatic or periampullary tumours: a multicentre randomised trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970172-4

7 January 2021

Efficacy of stapler versus hand-sewn closure after distal pancreatectomy (DISPACT): a randomised, controlled multicentre trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970172-4

7 January 2021

A dual-institution randomized controlled trial of remnant closure after distal pancreatectomy: does the addition of a falciform patch and fibrin glue improve outcomes?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970172-4

7 January 2021

Randomized clinical trial of techniques for closure of the pancreatic remnant following distal pancreatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970172-4

7 January 2021

The effect of prophylactic transpapillary pancreatic stent insertion on clinically significant leak rate following distal pancreatectomy: results of a prospective controlled clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970172-4

7 January 2021

Somatostatin analogues for pancreatic surgery

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970172-4

7 January 2021

Systematic review and meta-analysis of somatostatin analogues for the treatment of pancreatic fistula

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970172-4

7 January 2021

Pylorus ring resection reduces delayed gastric emptying in patients undergoing pancreatoduodenectomy: a prospective, randomized, controlled trial of pylorus-resecting versus pylorus-preserving pancreatoduodenectomy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970172-4

7 January 2021

Improvement of delayed gastric emptying in pylorus-preserving pancreaticoduodenectomy: results of a prospective, randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970172-4

7 January 2021

Preoperative biliary drainage for cancer of the head of the pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970172-4

7 January 2021

Therapeutic delay and survival after surgery for cancer of the pancreatic head with or without preoperative biliary drainage

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970172-4

7 January 2021

Laparoscopic distal pancreatectomy is associated with significantly less overall morbidity compared to the open technique: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970172-4

7 January 2021

A multicenter analysis of distal pancreatectomy for adenocarcinoma: is laparoscopic resection appropriate?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970172-4

7 January 2021

Total laparoscopic pancreaticoduodenectomy: feasibility and outcome in an early experience

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970172-4

7 January 2021

Relationship between hospital volume, system clinical resources, and mortality in pancreatic resection

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970172-4

7 January 2021

Variation in hospital mortality associated with inpatient surgery

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970172-4

7 January 2021

Changes in morbidity after pancreatic resection: toward the end of completion pancreatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970172-4

7 January 2021

Hospital volume and surgical mortality in the United States.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970172-4

7 January 2021

Hospital volume and late survival after cancer surgery

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970172-4

7 January 2021

Systematic review and meta-analysis of the volume-outcome relationship in pancreatic surgery.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970172-4

7 January 2021

Surgeon volume and operative mortality in the United States.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970172-4

7 January 2021

Multimodality therapy for pancreatic cancer in the U.S. : utilization, outcomes, and the effect of hospital volume

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970172-4

7 January 2021

Trends in hospital volume and operative mortality for high-risk surgery

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970172-4

7 January 2021

Improving outcome for patients with pancreatic cancer through centralization.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970172-4

7 January 2021

Influence of resection margins and treatment on survival in patients with pancreatic cancer: meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970172-4

7 January 2021

Prognostic nomogram for patients undergoing resection for adenocarcinoma of the pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970172-4

7 January 2021

Classification of pancreatic cancer: comparison of Japanese and UICC classifications

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970172-4

7 January 2021

Validation of the 6th edition AJCC Pancreatic Cancer Staging System: report from the National Cancer Database

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970172-4

7 January 2021

Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970172-4

7 January 2021

Extended pancreaticoduodenectomy with vascular resection for pancreatic cancer: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970172-4

7 January 2021

Pancreatectomy combined with superior mesenteric vein-portal vein resection for pancreatic cancer: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970172-4

7 January 2021

Impact of total lymph node count and lymph node ratio on staging and survival after pancreatectomy for pancreatic adenocarcinoma: a large, population-based analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970172-4

7 January 2021

A comparison of pancreaticoduodenectomy with extended pancreaticoduodenectomy: a meta-analysis of 1909 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970172-4

7 January 2021

Positive mobilization margins alone do not influence survival following pancreatico-duodenectomy for pancreatic ductal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970172-4

7 January 2021

'Artery-first' approaches to pancreatoduodenectomy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970172-4

7 January 2021

Uncinate process first--a novel approach for pancreatic head resection

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970172-4

7 January 2021

Preliminary experience with the hanging maneuver for pancreaticoduodenectomy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970172-4

7 January 2021

Total pancreatectomy for pancreatic adenocarcinoma: evaluation of morbidity and long-term survival

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970172-4

7 January 2021

Quality-of-life after total pancreatectomy: is it really that bad on long-term follow-up?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970172-4

7 January 2021

Total pancreatectomy (R0 resection) improves survival over subtotal pancreatectomy in isolated neck margin positive pancreatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970172-4

7 January 2021

Arterial resection during pancreatectomy for pancreatic cancer: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970172-4

7 January 2021

Multivisceral resection for pancreatic malignancies: risk-analysis and long-term outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970172-4

7 January 2021

Multivisceral resections in pancreatic cancer: identification of risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970172-4

7 January 2021

Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970172-4

7 January 2021

Adjuvant 5-fluorouracil and folinic acid vs observation for pancreatic cancer: composite data from the ESPAC-1 and -3(v1) trials

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970172-4

7 January 2021

A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970172-4

7 January 2021

Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970172-4

7 January 2021

Meta-analysis of randomised adjuvant therapy trials for pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970172-4

7 January 2021

Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970172-4

7 January 2021

Open-label, multicenter, randomized phase III trial of adjuvant chemoradiation plus interferon Alfa-2b versus fluorouracil and folinic acid for patients with resected pancreatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970172-4

7 January 2021

Re-resection for isolated local recurrence of pancreatic cancer is feasible, safe, and associated with encouraging survival

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970172-4

7 January 2021

10.1016/S1470-2045(13)70172-4

Identifiers

DOI

1 reference

29 August 2017

1 reference